GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...
Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.
Multiple ransomware gangs are using a packer-as-a-service platform named Shanya to help them deploy payloads that disable endpoint detection and response solutions on victim systems. Packer services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback